Cargando…
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
BACKGROUND: On March 16, 2020, the federal government of Austria declared a nationwide lockdown due to the COVID-19 pandemic. Since the lockdown, screening examinations and routine checkups have been restricted to prevent the spread of the virus and to increase the hospitals’ bed capacity across the...
Autores principales: | Tsibulak, Irina, Reiser, Elisabeth, Bogner, Gerhard, Petru, Edgar, Hell-Teutsch, Johanna, Reinthaller, Alexander, Weirather, Cornelia, Weiss, Tatjana, Bozsa, Szabolcs, Puschacher, Barbara, Hall, Mirijam, Hittler, Doris, Hrauda, Katharina, Thell, Elisabeth, Clauss, Sabine, Pozniak, Johanna, Alicke, Sebastian, Gangl, Daniela, Gamperl, Gottfried, Ebner, Christoph, Knoll, Katharina, Leitner, Katharina, Schilcher, Andrea, Schinnerl, Marina, Sigl, Verena, Singer, Christian, Aigmüller, Thomas, Hofstätter, Birgit, Marth, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656153/ https://www.ncbi.nlm.nih.gov/pubmed/33033166 http://dx.doi.org/10.1136/ijgc-2020-001975 |
Ejemplares similares
-
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective
por: Knoll, Katharina, et al.
Publicado: (2021) -
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2022) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020) -
Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2019) -
AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS)
por: Zeimet, Alain G., et al.
Publicado: (2017)